연구성과로 돌아가기
2024 연구자 정보 (966 / 1079)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Lee, Young Soo (Lee, YS) |
Daegu Catholic Univ, Med Ctr, Daegu, South Korea Daegu Catholic Univ, Med Ctr, Dept Internal Med, Div Cardiol, Daegu, South Korea |
|
|
[JCR상위 59.3] Performance and Physician Experience of INGEVITY plus Active Fixation Leads: Prospective INGEVITY plus Lead Clinical Study in Korea [JCR상위 62.0] Evaluation of ventricular pacing suppression algorithms in dual chamber pacemaker: Results of "LEADER" study |
SCIE ESCI |
59.3 | CARDIAC & CARDIOVASCULAR SYSTEMS |
cby6908@yuhs.ac;bmh0325@knu.ac.kr;dr.ilyoung.oh@gmail.com;drparkgyver@dsmc.or.kr;jaemins@korea.ac.kr;d070294@gmail.com;cardioljm@gmail.com;choiek417@gmail.com;mdleeys@cu.ac.kr; swhan@dsmc.or.kr; |
||
|
Oh, Il-Young (Oh, I) |
Seoul Natl Univ, Bundang Hosp, Soengnam Si, South Korea |
ACC-0418-2022 Oh, Il-Young |
|
[JCR상위 59.3] Performance and Physician Experience of INGEVITY plus Active Fixation Leads: Prospective INGEVITY plus Lead Clinical Study in Korea | SCIE | 59.3 | CARDIAC & CARDIOVASCULAR SYSTEMS | cby6908@yuhs.ac;bmh0325@knu.ac.kr;dr.ilyoung.oh@gmail.com;drparkgyver@dsmc.or.kr;jaemins@korea.ac.kr;d070294@gmail.com;cardioljm@gmail.com;choiek417@gmail.com;mdleeys@cu.ac.kr; | ||
|
Park, Hyung-Seob (Park, HS) |
Keimyung Univ Hosp, Daegu, South Korea |
|
|
[JCR상위 59.3] Performance and Physician Experience of INGEVITY plus Active Fixation Leads: Prospective INGEVITY plus Lead Clinical Study in Korea | SCIE | 59.3 | CARDIAC & CARDIOVASCULAR SYSTEMS | cby6908@yuhs.ac;bmh0325@knu.ac.kr;dr.ilyoung.oh@gmail.com;drparkgyver@dsmc.or.kr;jaemins@korea.ac.kr;d070294@gmail.com;cardioljm@gmail.com;choiek417@gmail.com;mdleeys@cu.ac.kr; | ||
|
Shim, Jaemin (Shim, J) |
Korea Univ Hosp, Ansan, Seoul, South Korea Korea Univ, Med Ctr, Dept Internal Med, Div Cardiol, Seoul, South Korea |
|
|
[JCR상위 59.3] Performance and Physician Experience of INGEVITY plus Active Fixation Leads: Prospective INGEVITY plus Lead Clinical Study in Korea [JCR상위 62.0] Evaluation of ventricular pacing suppression algorithms in dual chamber pacemaker: Results of "LEADER" study |
SCIE ESCI |
59.3 | CARDIAC & CARDIOVASCULAR SYSTEMS |
cby6908@yuhs.ac;bmh0325@knu.ac.kr;dr.ilyoung.oh@gmail.com;drparkgyver@dsmc.or.kr;jaemins@korea.ac.kr;d070294@gmail.com;cardioljm@gmail.com;choiek417@gmail.com;mdleeys@cu.ac.kr; swhan@dsmc.or.kr; |
||
|
Bae, Sang-Cheol (Bae, SC) |
교신저자 |
Hanyang Univ, Hosp Rheumat Dis, Inst Rheumatol, Dept Rheumatol, Seoul, South Korea Hanyang Univ, Inst Biosci & Biotechnol, Seoul, South Korea Hanyang Univ, Hosp Rheumat Dis, Seoul 04763, South Korea |
P-2051-2015 Bae, Sang-Cheol |
|
[JCR상위 59.5] Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia | SCIE | 59.5 | RHEUMATOLOGY | scbae@hanyang.ac.kr; | |
|
Cho, Chul-Soo (Cho, CS) |
Catholic Univ Korea, Yeouido St Marys Hosp, Dept Internal Med, Div Rheumatol, Seoul, South Korea |
|
|
[JCR상위 59.5] Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia | SCIE | 59.5 | RHEUMATOLOGY | scbae@hanyang.ac.kr; | ||
|
Chung, Won Tae (Chung, WT) |
Dong A Univ Hosp, Dept Internal Med, Div Rheumatol, Busan, South Korea |
|
|
[JCR상위 59.5] Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia | SCIE | 59.5 | RHEUMATOLOGY | scbae@hanyang.ac.kr; | ||
|
Hammer, Anne (Hammer, A) |
GSK, Immunol Biostat, Collegeville, PA USA |
|
|
[JCR상위 59.5] Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia | SCIE | 59.5 | RHEUMATOLOGY | scbae@hanyang.ac.kr; | ||
|
Karuppiah, Marimuthu (Karuppiah, M) |
Presidency Univ, Sch Comp Sci & Engn & Informat Sci, Bengaluru, Karnataka, India |
B-2653-2018 Karuppiah, Marimuthu |
0000-0001-7379-2641 Karuppiah, Marimuthu |
[JCR상위 59.5] Designing access control security protocol for Industry 4.0 using Blockchain-as-a-Service | ESCI | 59.5 | TELECOMMUNICATIONS;COMPUTER SCIENCE, INFORMATION SYSTEMS | iitkgp.akdas@gmail.com; | ||
|
Kumar, Neeraj (Kumar, N) |
Thapar Univ, Dept Comp Sci & Engn, Patiala, India Thapar Univ, Dept Comp Sci & Engn, Patiala 147004, India |
L-3500-2016 ABA-5200-2021 Kumar, Neeraj |
0000-0002-3020-3947 Kumar, Neeraj |
[JCR상위 59.5] Designing access control security protocol for Industry 4.0 using Blockchain-as-a-Service [JCR상위 11.1] Big Data-Enabled Authentication Framework for Offshore Maritime Communication Using Drones |
ESCI SCIE |
11.1 |
TELECOMMUNICATIONS;COMPUTER SCIENCE, INFORMATION SYSTEMS ENGINEERING, ELECTRICAL & ELECTRONIC;TELECOMMUNICATIONS;TRANSPORTATION SCIENCE & TECHNOLOGY |
iitkgp.akdas@gmail.com; anusha.vangala@research.iiit.ac.in;saurabh.agrawal@research.iiit.ac.in;ashok.das@iiit.ac.in;shantanu.pal@deakin.edu.au;neeraj.kumar@thapar.edu;lorenz@ieee.org;parkyh@knu.ac.kr; |
||
|
Kwok, Seung-Ki (Kwok, SK) |
Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Rheumatol, Seoul, South Korea |
|
|
[JCR상위 59.5] Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia | SCIE | 59.5 | RHEUMATOLOGY | scbae@hanyang.ac.kr; | ||
|
Lee, Seung-Geun (Lee, SG) |
Pusan Natl Univ Hosp, Dept Internal Med, Div Rheumatol, Busan, South Korea |
|
|
[JCR상위 59.5] Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia | SCIE | 59.5 | RHEUMATOLOGY | scbae@hanyang.ac.kr; | ||
|
Lee, Yoonhee (Lee, YH) |
GSK, Med Affairs, Singapore, Singapore |
|
|
[JCR상위 59.5] Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia | SCIE | 59.5 | RHEUMATOLOGY | scbae@hanyang.ac.kr; | ||
|
Quasny, Holly (Quasny, H) |
Clin Sci, GSK, Durham, NC USA |
|
0000-0002-1659-0004 Quasny, Holly |
[JCR상위 59.5] Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia | SCIE | 59.5 | RHEUMATOLOGY | scbae@hanyang.ac.kr; | ||
|
Rojas, Aldo Amador Navarro (Rojas, AAN) |
GSK, Med Affairs, Singapore, Singapore |
|
|
[JCR상위 59.5] Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia | SCIE | 59.5 | RHEUMATOLOGY | scbae@hanyang.ac.kr; |
페이지 이동: